Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
In the SURMOUNT-5 trial, published in the New England Journal of Medicine in 2025, people taking tirzepatide lost an average of 20.2% of their body weight over 72 weeks, compared with 13.7% for those taking semaglutide
A Ro-affiliated provider will review your responses and determine if youre a fit for GLP-1 treatment within a few days
Loss of fat is gradual and permanent, and therefore it is suitable for first-time users
Consult Your Physician: Document eligibility and ensure all requisite codes are used in the authorization process
International Society for the Study of Xenobiotics (ISSX)
GLP-1 Market for Biologics, till 2035 12.2.2
US$ 28.06
US$ 24.88
US$ 26.47
US$ 26.20
